131 related articles for article (PubMed ID: 12084983)
1. Monoclonal antibody (5F3) defining renal cell carcinoma-associated antigen disialosyl globopentaosylceramide (V3NeuAcIV6NeuAcGb5), and distribution pattern of the antigen in tumor and normal tissues.
Ito A; Saito S; Masuko T; Oh-Eda M; Matsuura T; Satoh M; Nejad FM; Enomoto T; Orikasa S; Hakomori SI
Glycoconj J; 2001 Jun; 18(6):475-85. PubMed ID: 12084983
[TBL] [Abstract][Full Text] [Related]
2. A novel ganglioside isolated from renal cell carcinoma.
Ito A; Levery SB; Saito S; Satoh M; Hakomori S
J Biol Chem; 2001 May; 276(20):16695-703. PubMed ID: 11278988
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside disialosyl globopentaosylceramide is an independent predictor of PSA recurrence-free survival following radical prostatectomy.
Shimada S; Ito A; Kawasaki Y; Kakoi N; Taima T; Mitsuzuka K; Watanabe M; Saito S; Arai Y
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):199-205. PubMed ID: 24637536
[TBL] [Abstract][Full Text] [Related]
4. Disialosyl galactosylgloboside as an adhesion molecule expressed on renal cell carcinoma and its relationship to metastatic potential.
Satoh M; Handa K; Saito S; Tokuyama S; Ito A; Miyao N; Orikasa S; Hakomori S
Cancer Res; 1996 Apr; 56(8):1932-8. PubMed ID: 8620516
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of ganglioside DSGb5 expression in renal cell carcinoma.
Itoh J; Ito A; Shimada S; Kawasaki Y; Kakoi N; Saito H; Mitsuzuka K; Watanabe M; Satoh M; Saito S; Arai Y
Glycoconj J; 2017 Apr; 34(2):267-273. PubMed ID: 28205070
[TBL] [Abstract][Full Text] [Related]
6. Novel fucolipids of human adenocarcinoma: disialosyl Lea antigen (III4FucIII6NeuAcIV3NeuAcLc4) of human colonic adenocarcinoma and the monoclonal antibody (FH7) defining this structure.
Nudelman E; Fukushi Y; Levery SB; Higuchi T; Hakomori S
J Biol Chem; 1986 Apr; 261(12):5487-95. PubMed ID: 3957932
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical comparison of Lea, monosialosyl Lea (CA 19-9), and disialosyl Lea antigens in human colorectal and pancreatic tissues.
Itzkowitz SH; Yuan M; Fukushi Y; Lee H; Shi ZR; Zurawski V; Hakomori S; Kim YS
Cancer Res; 1988 Jul; 48(13):3834-42. PubMed ID: 3288336
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific monoclonal antibodies for renal cell carcinoma.
Schärfe T; Becht E; Kaltwasser R; Thüroff JW; Jacobi GH; Hohenfellner R
Eur Urol; 1985; 11(2):117-20. PubMed ID: 2408893
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside, disialosyl globopentaosylceramide (DSGb5), enhances the migration of renal cell carcinoma cells.
Kawasaki Y; Ito A; Kakoi N; Shimada S; Itoh J; Mitsuzuka K; Arai Y
Tohoku J Exp Med; 2015 May; 236(1):1-7. PubMed ID: 25864532
[TBL] [Abstract][Full Text] [Related]
10. Chemoenzymatic synthesis of the oligosaccharide moiety of the tumor-associated antigen disialosyl globopentaosylceramide.
't Hart IME; Li T; Wolfert MA; Wang S; Moremen KW; Boons GJ
Org Biomol Chem; 2019 Aug; 17(31):7304-7308. PubMed ID: 31339142
[TBL] [Abstract][Full Text] [Related]
11. Cell surface reactive human monoclonal antibody directed to human melanoma-associated gangliosides.
Abdel-Wahab Z; Li WP; Darrow T; Nudelman ED; Towell A; Seigler HF
Melanoma Res; 1993 Dec; 3(6):415-23. PubMed ID: 8161881
[TBL] [Abstract][Full Text] [Related]
12. High incidence of GalNAc disialosyl lactotetraosylceramide in metastatic renal cell carcinoma.
Maruyama R; Saito S; Bilim V; Hara N; Itoi T; Yamana K; Nishiyama T; Arai Y; Takahashi K; Tomita Y
Anticancer Res; 2007; 27(6C):4345-50. PubMed ID: 18214042
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens.
Vessella RL; Moon TD; Chiou RK; Nowak JA; Arfman EW; Palme DF; Peterson GA; Lange PH
Cancer Res; 1985 Dec; 45(12 Pt 1):6131-9. PubMed ID: 3904980
[TBL] [Abstract][Full Text] [Related]
14. Expression of globo-series gangliosides in human renal cell carcinoma.
Saito S; Orikasa S; Satoh M; Ohyama C; Ito A; Takahashi T
Jpn J Cancer Res; 1997 Jul; 88(7):652-9. PubMed ID: 9310138
[TBL] [Abstract][Full Text] [Related]
15. A highly restricted antigen for renal cell carcinoma defined by a monoclonal antibody.
Moon TD; Vessella RL; Palme DF; Nowak JA; Lange PH
Hybridoma; 1985; 4(2):163-71. PubMed ID: 3891589
[TBL] [Abstract][Full Text] [Related]
16. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
Kinouchi T; Bander NH; Kotake T
J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to kidney and tumor-associated surface antigens of human renal cell carcinoma.
Luner SJ; Ghose T; Chatterjee S; Cruz HN; Belitsky P
Cancer Res; 1986 Nov; 46(11):5816-20. PubMed ID: 3530441
[TBL] [Abstract][Full Text] [Related]
18. [Production of monoclonal antibody to renal cell carcinoma].
Terashima Y; Kanamori S; Hattori T; Kimura G; Akimoto M
Nihon Hinyokika Gakkai Zasshi; 1989 Jun; 80(6):838-46. PubMed ID: 2677465
[TBL] [Abstract][Full Text] [Related]
19. Common tetrasaccharide epitope NeuAc alpha 2-->3Gal beta 1-->3(Neu-Ac alpha 2-->6)GalNAc, presented by different carrier glycosylceramides or O-linked peptides, is recognized by different antibodies and ligands having distinct specificities.
Saito S; Levery SB; Salyan ME; Goldberg RI; Hakomori S
J Biol Chem; 1994 Feb; 269(8):5644-52. PubMed ID: 7509790
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'.
McGregor DK; Khurana KK; Cao C; Tsao CC; Ayala G; Krishnan B; Ro JY; Lechago J; Truong LD
Am J Surg Pathol; 2001 Dec; 25(12):1485-92. PubMed ID: 11717537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
